Chemed Reports First-Quarter 2019 Results

CINCINNATI–(BUSINESS WIRE)–Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS
Healthcare Corporation (VITAS), one of the nation’s largest providers of
end-of-life care, and Roto-Rooter, the nation’s largest commercial and
residential plumbing and drain cleaning services provider, reported
financial results for its first quarter ended March 31, 2019, versus the
comparable prior-year period, as follows:

Consolidated operating results:

• Revenue increased 5.2% to $462 million
• GAAP Diluted Earnings-per-Share (EPS) of $2.70
• Adjusted Diluted EPS of $2.92, an increase of 7.4%

VITAS segment operating results:

• Net Patient Revenue of $307 million, an increase of 5.1%
• Average Daily Census (ADC) of 18,345, an increase of 6.6%
• Admissions of 17,758, a decline of 2.9%
• Net Income, excluding certain discrete items, of $34.6 million, an
  increase of 7.3%
• Adjusted EBITDA, excluding cap, of $49.7 million, an increase of 16.0%

Roto-Rooter segment operating results:

• Revenue of $155 million, an increase of 5.5%
• Net Income, excluding certain discrete items, of $23.3 million, an
  increase of 1.8%
• Adjusted EBITDA of $33.5 million, a slight decline of 1.1%
• Adjusted EBITDA margin of 21.6%, a decrease of 145-basis points

VITAS

VITAS net revenue was $307 million in the first quarter of 2019, which
is an increase of 5.1%, when compared to the prior-year period. This
revenue increase is comprised primarily of a geographically weighted
average Medicare reimbursement rate increase of approximately 0.6% and a
6.6% increase in days-of-care. This growth was partially offset by a
Medicare Cap billing limitation that decreased revenue growth by 1.8% as
well as the combination of acuity mix shift, fluctuations in net room
and board and contractual adjustments, the combination of which
negatively impacted revenue growth 0.4%, when compared to the prior-year
period.

In the first quarter of 2019, VITAS accrued $3.4 million in Medicare Cap
billing limitations. At March 31, 2019, VITAS had 30 Medicare provider
numbers, three of which have an estimated 2019 calendar year Medicare
Cap billing limitation of approximately $10 million.

Of VITAS’ 30 Medicare provider numbers, on a trailing 12-month basis, 25
provider numbers have a Medicare Cap cushion of 10% or greater, one
provider number has a cap cushion between 5% and 10%, one provider
number has a cap cushion between 0% and 5%, and three provider numbers
have a Medicare Cap billing limitation.

Average revenue per patient per day in the quarter was $191.20, which is
0.2% above the prior-year period. Reimbursement for routine home care
and high acuity care averaged $165.31 and $750.13, respectively. During
the quarter, high acuity days-of-care were 4.4% of total days of care,
22-basis points less than the prior-year quarter.

The first quarter of 2019 gross margin, excluding Medicare Cap, was
22.7%, which is a 102-basis point increase when compared to the first
quarter of 2018.

Selling, general and administrative expense was $21.5 million in the
first quarter of 2019, which is an increase of 5.0% compared to the
prior-year quarter. Adjusted EBITDA, excluding Medicare Cap, totaled
$49.7 million in the quarter, an increase of 16.0%. Adjusted EBITDA
margin, excluding Medicare Cap, was 16.0% in the quarter, which is a
126-basis point increase when compared to the prior-year period.

Roto-Rooter

Roto-Rooter generated quarterly revenue of $155 million for the first
quarter of 2019, an increase of $8.1 million, or 5.5%, over the
prior-year quarter. Revenue from the water restoration service segment
totaled $27.7 million, a decrease of 0.3%, when compared to the
prior-year quarter. Approximately 90% of the water restoration revenue
is generated from residential customers and the remaining 10% is
generated from commercial accounts.

Commercial drain cleaning revenue increased 8.3%, commercial plumbing
and excavation increased 5.3% and commercial water restoration declined
26.4%. Overall, commercial revenue increased 3.4%.

Residential drain cleaning increased 5.8%, plumbing and excavation
increased 7.5% and residential water restoration increased 3.8%.
Aggregate residential sales increased 5.9%.

Roto-Rooter’s gross margin in the quarter was 47.0%, a 44-basis point
decline when compared to the first quarter of 2018. Adjusted EBITDA in
the first quarter of 2019 totaled $33.5 million, a decrease of 1.1%. The
Adjusted EBITDA margin in the quarter was 21.6% which is a 145-basis
point decline over the prior year.

Chemed Consolidated

As of March 31, 2019, Chemed had total cash and cash equivalents of $9
million and debt of $100 million.

In June 2018, Chemed entered into a five-year Amended and Restated
Credit Agreement that consists of a $450 million revolving credit
facility. The interest rate on this facility has a floating rate that is
currently LIBOR plus 100-basis points. At March 31, 2019, the Company
had approximately $314 million of undrawn borrowing capacity under this
credit agreement.

During the quarter, the Company repurchased 150,000 shares of Chemed
stock for $49.2 million, which equates to a cost per share of $328.33.
On February 22, 2019, Chemed’s Board of Directors authorized an
additional $150 million for stock repurchase under Chemed’s existing
share repurchase program. As of March 31, 2019, there was approximately
$147 million of remaining share repurchase authorization under this plan.

Chemed restarted its share repurchase program in 2007. Since that time
Chemed has repurchased over 14 million shares, aggregating approximately
$1.2 billion at an average share cost of $83.56. Including dividends
over this period, Chemed has returned approximately $1.3 billion to
shareholders.

Guidance for 2019

Revenue growth for VITAS in 2019, prior to Medicare Cap, is estimated to
be in the range of 5.5% to 6.0%. Admissions are estimated to expand
approximately 3.0% to 4.0% and Average Daily Census in 2019 is estimated
to expand approximately 4.0% to 5.0%. Full-year Adjusted EBITDA margin,
prior to Medicare Cap, is estimated to be 15.9%. We are currently
estimating $10 million for Medicare Cap billing limitations in calendar
2019.

Roto-Rooter is forecasted to achieve full-year 2019 revenue growth of
9.0% to 10.0%. This revenue estimate is based upon increased job pricing
of approximately 2%, continued growth in core plumbing and drain
cleaning services as well as continued but slowing revenue growth from
water restoration services. Roto-Rooter’s Adjusted EBITDA margin for
2019 is estimated at 23.7%.

Based upon the above, full-year 2019 adjusted earnings per diluted
share, excluding non-cash expense for stock options, tax benefits from
stock options, costs related to litigation, and other discrete items, is
estimated to be in the range of $12.65 to $12.85. This 2019 guidance
assumes an effective corporate tax rate of 25.2%. Chemed’s 2018 reported
adjusted earnings per diluted share was $11.93.

Conference Call

Chemed will host a conference call and webcast at 10 a.m., ET, on
Tuesday, April 30, 2019, to discuss the Company’s quarterly results and
to provide an update on its business. The dial-in number for the
conference call is (844) 743-2500 for U.S. and Canadian participants and
+1 (661) 378-9533 for international participants. The participant
passcode/Conference ID is 5375966. A live webcast of the call can be
accessed on Chemed’s website at www.chemed.com
by clicking on Investor Relations Home.

A taped replay of the conference call will be available beginning
approximately 24 hours after the call’s conclusion. It can be accessed
by dialing (855) 859-2056 for U.S. and Canadian callers and +1 (404)
537-3406 for international callers and will be available for one week
following the live call. The replay Conference ID is 5375966. An
archived webcast will also be available at www.chemed.com.

Chemed Corporation operates in the healthcare field through its VITAS
Healthcare Corporation subsidiary. VITAS provides daily hospice services
to approximately 18,500 patients with severe, life-limiting illnesses.
This type of care is focused on making the terminally ill patient’s
final days as comfortable and pain-free as possible.

Chemed operates in the residential and commercial plumbing and drain
cleaning industry under the brand name Roto-Rooter. Roto-Rooter provides
plumbing, drain cleaning, and water cleanup services through
company-owned branches, independent contractors and franchisees in the
United States and Canada. Roto-Rooter also has licensed master
franchisees in the republics of Indonesia and Singapore, and the
Philippines.

This press release contains information about Chemed’s EBITDA, Adjusted
EBITDA and Adjusted Diluted EPS, which are not measures derived in
accordance with GAAP and which exclude components that are important to
understanding Chemed’s financial performance. In reporting its operating
results, Chemed provides EBITDA, Adjusted EBITDA and Adjusted Diluted
EPS measures to help investors and others evaluate the Company’s
operating results, compare its operating performance with that of
similar companies that have different capital structures and evaluate
its ability to meet its future debt service, capital expenditures and
working capital requirements. Chemed’s management similarly uses EBITDA,
Adjusted EBITDA and Adjusted Diluted EPS to assist it in evaluating the
performance of the Company across fiscal periods and in assessing how
its performance compares to its peer companies. These measures also help
Chemed’s management to estimate the resources required to meet Chemed’s
future financial obligations and expenditures. Chemed’s EBITDA, Adjusted
EBITDA and Adjusted Diluted EPS should not be considered in isolation or
as a substitute for comparable measures calculated and presented in
accordance with GAAP. We calculated Adjusted EBITDA Margin by dividing
Adjusted EBITDA by service revenue and sales. A reconciliation of
Chemed’s net income to its EBITDA, Adjusted EBITDA and Adjusted Diluted
EPS is presented in the tables following the text of this press release.

Forward-Looking Statements

Certain statements contained in this press release and the accompanying
tables are “forward-looking statements” within the meaning of the
Private Securities Litigation Reform Act of 1995. The words “believe,”
“expect,” “hope,” “anticipate,” “plan” and similar expressions identify
forward-looking statements, which speak only as of the date the
statement was made. Chemed does not undertake and specifically disclaims
any obligation to publicly update or revise any forward-looking
statements, whether as a result of new information, future events or
otherwise. These statements are based on current expectations and
assumptions and involve various risks and uncertainties, which could
cause Chemed’s actual results to differ from those expressed in such
forward-looking statements.

These risks and uncertainties arise from, among other things, possible
changes in regulations governing the hospice care or plumbing and drain
cleaning industries; periodic changes in reimbursement levels and
procedures under Medicare and Medicaid programs; difficulties predicting
patient length of stay and estimating potential Medicare reimbursement
obligations; challenges inherent in Chemed’s growth strategy; the
current shortage of qualified nurses, other healthcare professionals and
licensed plumbing and drain cleaning technicians; Chemed’s dependence on
patient referral sources; and other factors detailed under the caption
“Description of Business by Segment” or “Risk Factors” in Chemed’s most
recent report on form 10-Q or 10-K and its other filings with the
Securities and Exchange Commission. You are cautioned not to place undue
reliance on such forward-looking statements and there are no assurances
that the matters contained in such statements will be achieved.

Contacts

David P. Williams
(513) 762-6901

Read full story here